BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akashi D, Todo Y, Shimada C, Okamoto K, Minobe S, Kato H. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report. Jpn J Clin Oncol 2013;43:1145-9. [PMID: 24058200 DOI: 10.1093/jjco/hyt142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Wu M, Lou W, Lou M, Fu P, Yu XF. Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma. Front Oncol 2020;10:576615. [PMID: 33194689 DOI: 10.3389/fonc.2020.576615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maenohara S, Fujimoto T, Okadome M, Sonoda K, Taguchi K, Saito T. Potential alternative progestin therapy for low-grade endometrial stromal sarcoma: A case report. Gynecol Oncol Rep 2020;34:100634. [PMID: 32953963 DOI: 10.1016/j.gore.2020.100634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Loures FH, Conceição LG, Amorim RL, Nobrega J, T. Neto R, Costa EP, Silva FFE. Progesterone and estrogen receptor expression by canine cutaneous soft tissue sarcomas. Pesq Vet Bras 2020;40:284-8. [DOI: 10.1590/1678-5150-pvb-6103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Fadeeva EP, Lisyanskaya AS, Manikhas GM, Glushakov RI, Tapilskaya NI. Aromatase inhibitors of the third generation in endocrine therapy of breast cancer and endometrial cancer: the successes and failures of the combination therapy. Rev Clin Pharm Drug Ther 2016;14:47-57. [DOI: 10.17816/rcf14247-57] [Reference Citation Analysis]
5 Yamazaki H, Todo Y, Mitsube K, Hareyama H, Shimada C, Kato H, Yamashiro K. Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study. J Gynecol Oncol 2015;26:214-21. [PMID: 25925291 DOI: 10.3802/jgo.2015.26.3.214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
6 Carboplatin/docetaxel/leuprorelin. Reactions Weekly 2014;1501:13-13. [DOI: 10.1007/s40278-014-0776-y] [Reference Citation Analysis]